Ultrasensitive in-house reverse transcription-competitive PCR for quantitation of HIV-1 RNA in plasma

Citation
G. Venturi et al., Ultrasensitive in-house reverse transcription-competitive PCR for quantitation of HIV-1 RNA in plasma, J VIROL MET, 87(1-2), 2000, pp. 91-97
Citations number
16
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF VIROLOGICAL METHODS
ISSN journal
01660934 → ACNP
Volume
87
Issue
1-2
Year of publication
2000
Pages
91 - 97
Database
ISI
SICI code
0166-0934(200006)87:1-2<91:UIRTPF>2.0.ZU;2-L
Abstract
An ultrasensitive version of an 'in-house' reverse transcription-competitiv e polymerase chain reaction assay described previously for quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in plasma was developed. Th e increase in sensitivity from 400 to 50 HIV-1 RNA copies/ml was achieved b y pelleting virus particles from 1.8 ml plasma by centrifugation prior to R NA extraction, modifying competitor DNA structure and amounts, and redesign ing primers. Quantitation of HIV-1 RNA in 130 samples tested previously by the standard assay showed that the two procedures yield comparable results (mean absolute difference, 0.26 +/- 0.20 log) and that the ultrasensitive v ersion detects HIV-1 RNA below the threshold of sensitivity of the standard method. The ultrasensitive 'in-house assay' and the reference QUANTIPLEX H IV-1 RNA 3.0 had the same sensitivity and gave equivalent results (mean abs olute difference, 0.19+/-0.11 log), as shown by parallel blinded testing of 47 plasma samples. Titration experiments with reconstructed plasma samples allowed the determination of a dynamic range of 50500 000 HIV-I RNA copies /ml for the 'in-house' system. The interassay coefficient of variation for samples nominally containing 200, 4000 and 80 000 HIV-1 RNA copies/ml were 33.4, 22.9 and 38.2%, respectively. The performance, turnaround time, and c ost-effectiveness of this system make it suitable for medium-scale clinical application. (C) 2000 Elsevier Science B.V. All rights reserved.